Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)

Clinical trial NCT04926467 · RECRUITING

Trial details

NCT number: NCT04926467
Sponsor: Baylor Research Institute
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Adenocarcinoma

Start date: 2021-07-23
Primary completion: 2026-06-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.